Population
140,981 US managed care enrollees ≥40 years old with an inpatient admission with a primary diagnosis of COPD
Design
Cohort
Follow-up
up to 90 days
Key result
Among US managed care enrollees hospitalized for COPD, 30-day all-cause readmission occurred in nearly 20% of patients, with longer length of stay, older age, and comorbidities increasing risk.
Authors
Loading...
Identifies COPD readmission risks in managed care; hypothesis-generating for targeted prevention trials.
Cohort (n=140,981)
In a large US managed care population with COPD, longer length of stay, older age, and greater comorbidity burden are significant predictors of 30- and 90-day readmission.
Candrilli et al. (2015) conducted a cohort in Chronic obstructive pulmonary disease (COPD) (n=140,981). Patient characteristics (length of stay, age, comorbidity burden, COPD complexity) was evaluated on 30-day and 90-day COPD-related and all-cause readmission. Among US managed care enrollees hospitalized for COPD, 30-day all-cause readmission occurred in nearly 20% of patients, with longer length of stay, older age, and comorbidities increasing risk.